All In Biotech

Free tool

FAERS Monitor: Perforomist

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022007 or its brand name (Perforomist, Formoterol Fumarate). Reports on generic versions are filed under their own applications.

Reports

4,757

Serious

3,925

83% of reports

Hospitalization

2,152

Death reported

538

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,333
  • asthma1,150
  • cough727
  • wheezing608
  • pneumonia530
  • drug ineffective482
  • therapeutic product effect incomplete461
  • obstructive airways disorder430
  • fatigue425
  • headache405
  • gastrooesophageal reflux disease393
  • full blood count abnormal330
  • hypertension322
  • productive cough302
  • sleep disorder due to a general medical condition263

Reports by year received

View as table
YearReports
200429
200547
200666
200797
200866
200989
2010106
2011470
2012457
201380
201469
2015112
2016141
2017186
2018222
2019296
2020359
2021420
2022372
2023322
2024288
2025278
2026185

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,402 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
obstructive airways disorderSignal430177.8162.172,541
full blood count abnormalSignal330142.3128.044,756
sleep disorder due to a general medical conditionSignal26369.561.817,437
wheezingSignal60845.842.526,395
asthmaSignal1,15045.443.249,700
therapeutic product effect incompleteSignal46128.826.412,320
productive coughSignal30228.125.27,847
gastrooesophageal reflux diseaseSignal39321.719.77,726
coughSignal72711.510.77,027
dyspnoeaSignal1,33310.410.011,647
pneumoniaSignal5307.26.72,888
hypertensionSignal3226.76.11,579
headacheSignal4052.92.6502
fatigueSignal4252.42.2364
drug ineffective4821.61.5120

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.